Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pumilio RNA binding family member 2 (PUM2) is a member of the evolutionarily conserved PUF family of RNA-binding proteins, characterized by the presence of the Pumilio homology domain (PUM-HD) containing eight Puf repeats critical for RNA binding[4]. PUM2 regulates gene expression by binding to sequence motifs (such as the Pumilio Response Element: 5'-UGUANAUA-3') in the 3'-UTR of target mRNAs, leading to translational repression or mRNA degradation, often by recruitment of deadenylation complexes or by facilitating miRNA accessibility[1][2][3]. It interacts with DAZ and DAZL proteins and plays crucial roles in the development and maintenance of germ cells, embryogenesis, and neurogenesis[2][4]. While PUM2 is not currently recognized as a druggable therapeutic target and no approved drugs directly interact with it, its functions have been implicated in cell proliferation, fertility, and disease states such as cancer and neuronal disorders[1][2][3][4]. Key molecular features: Evolutionarily conserved, with homology across eukaryotes. Interacts with DAZ, DAZL, and other regulatory proteins in the germline. Regulates stability and translation of target mRNAs via PUF domain binding. Mainly located in the cytoplasm, especially in embryonic and germ cells[2]. PUM2 has extensive roles as a post-transcriptional regulator but is not currently a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pumilio RNA binding family member 2 (PUM2).